Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

• Paola Queirolo,
• Beatrice Dozin,
• Anna Morabito,
• Barbara Banelli,
• Barbara Banelli,
• Patrizia Piccioli,
• Cristiana Fava,
• Claudio Leo,
• Roberta Carosio,
• Stefania Laurent,
• Vincenzo Fontana,
• Pier Francesco Ferrucci,
• Chiara Martinoli,
• Emilia Cocorocchio,
• Angelo Battaglia,
• Paolo A. Ascierto,
• Mariaelena Capone,
• Ester Simeone,
• Federica De Galitiis,
• Elena Pagani,
• Gian Carlo Antonini Cappellini,
• Paolo Marchetti,
• Paolo Marchetti,
• Michele Guida,
• Stefania Tommasi,
• Mario Mandalà,
• Barbara Merelli,
• Pietro Quaglino,
• Paolo Fava,
• Massimo Guidoboni,
• Massimo Romani,
• Francesco Spagnolo,
• Maria Pia Pistillo

Affiliations

Paola Queirolo

Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Beatrice Dozin

Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Anna Morabito

Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Barbara Banelli

Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Barbara Banelli

Department of Health Sciences, University of Genova, Genova, Italy

Patrizia Piccioli

Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Cristiana Fava

Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Claudio Leo

Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Roberta Carosio

Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Stefania Laurent

Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy

Vincenzo Fontana

Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Pier Francesco Ferrucci

Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy

Chiara Martinoli

Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy

Emilia Cocorocchio

Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy

Angelo Battaglia

Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy

Paolo A. Ascierto

Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione ‘G. Pascale’, Naples, Italy

Mariaelena Capone

Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione ‘G. Pascale’, Naples, Italy

Ester Simeone

Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione ‘G. Pascale’, Naples, Italy

Federica De Galitiis

Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy

Elena Pagani

Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy

Gian Carlo Antonini Cappellini

Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy

Paolo Marchetti

Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy

Paolo Marchetti

0Medical Oncology, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy

Michele Guida

1Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori “Giovanni Paolo II,”Bari, Italy

Stefania Tommasi

1Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori “Giovanni Paolo II,”Bari, Italy

Mario Mandalà

2Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy

Barbara Merelli

2Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy

Pietro Quaglino

3Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy

Paolo Fava

3Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy

Massimo Guidoboni

4Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy

Massimo Romani

Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Francesco Spagnolo

Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Maria Pia Pistillo

Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy